Market Research Logo

Protein Therapeutics Market Analysis and Trends- Therapeutic Proteins (Bone morphogenetic proteins, Interferon (IFN), Insulin and Engineered protein scaffolds), Application (Cancer and Fertility), Function (Special targeting activity & Vaccines) - Forecas

Protein Therapeutics Market Analysis and Trends- Therapeutic Proteins (Bone morphogenetic proteins, Interferon (IFN), Insulin and Engineered protein scaffolds), Application (Cancer and Fertility), Function (Special targeting activity & Vaccines) - Forecast to 2025

The Global Protein Therapeutics Devices Market is poised to grow at a CAGR of around 8.6% over the next decade to reach approximately $315.90 billion by 2025. Some of the prominent trends that the market is witnessing include Hepatic metabolism and rapid elimination is a major setback to the clinical application of therapeutic proteins, Increasing focus on development of Biobetters, Recent innovations in Recombinant Protein drugs have changed the landscape and Rise of antibody based drugs have led to research on engineering protein scaffolds.
Based on Therapeutic Proteins the market is categorized into Monoclonal Antibodies (mAbs), Erythropoietin (EPO), Insulin, Interferon (IFN), Human Growth Hormone (HGH), Follicle Stimulating Hormone (FSH), Blood Clotting Factors, Granulocyte-colony stimulating factor (G-CSF), Colony Stimulating factor and Other Proteins. The Other Proteins segment is further divided as Interleukins, Enzyme Replacement, Bone morphogenetic proteins, Thrombolytic, Fc fusion proteins, engineered protein scaffolds and Cytokines.
Depending on the Application the market is segregated by Autoimmune diseases, Infectious diseases, Protein vaccine, Cancer, Fertility, Hematopoiesis & Metabolic and endocrine disorders.
The End User segment market is fragmented into Pharmaceutical companies, Healthcare service providers, Research Organizations and Academic Research Institutes.
The Function segment is divided into Protein diagnostics, Special targeting activity, Enzymatic & regulatory activity and Vaccines.

This industry report analyzes the global markets for Protein Therapeutics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Protein Therapeutics Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
US
Canada
Mexico

Europe
France
Germany
Italy
Spain
UK
Rest of Europe

Asia Pacific
China
Japan
India
Australia
New Zealand
Rest of Asia

Middle East
Saudi Arabia
UAE
Rest of Middle East

Latin America
Argentina
Brazil
Rest of Latin America

Rest of the World
Africa
Caribbean

Report Highlights:
The report provides a detailed analysis on current and future market trends to identify the investment opportunities
Market forecasts till 2025, using estimated market values as the base numbers
Key market trends across the business segments, Regions and Countries
Key developments and strategies observed in the market
Market Dynamics such as Drivers, Restraints, Opportunities and other trends
In-depth company profiles of key players and upcoming prominent players
Growth prospects among the emerging nations through 2025
Market opportunities and recommendations for new investments


1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Application Analysis
1.5 End User Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Hepatic metabolism and rapid elimination is a major setback to the clinical application of therapeutic proteins
3.1.2 Increasing focus on development of Biobetters
3.1.3 Recent innovations in Recombinant Protein drugs have changed the landscape
3.1.4 Rise of antibody based drugs have led to research on engineering protein scaffolds
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry
4 Protein Therapeutics Market, By Therapeutic Proteins
4.1 Monoclonal Antibodies(mAbs)
4.1.1Monoclonal Antibodies(mAbs) Market Forecast to 2025 (US$ MN)
4.2 Erythropoietin (EPO)
4.2.1 Erythropoietin (EPO) Market Forecast to 2025 (US$ MN)
4.3 Insulin
4.3.1 Insulin Market Forecast to 2025 (US$ MN)
4.4 Interferon (IFN)
4.4.1 Interferon (IFN) Market Forecast to 2025 (US$ MN)
4.5 Human Growth Hormone (HGH)
4.5.1 Human Growth Hormone (HGH) Market Forecast to 2025 (US$ MN)
4.6 Follicle Stimulating Hormone (FSH)
4.6.1 Follicle Stimulating Hormone (FSH) Market Forecast to 2025 (US$ MN)
4.7 Blood Clotting Factors
4.7.1 Blood Clotting Factors Market Forecast to 2025 (US$ MN)
4.8 Granulocyte-colony stimulating factor (G-CSF)
4.8.1 Granulocyte-colony stimulating factor (G-CSF) Market Forecast to 2025 (US$ MN)
4.9 Colony Stimulating factor
4.9.1 Colony Stimulating factor Market Forecast to 2025 (US$ MN)
4.10 Other Proteins
4.10.1 Other Proteins Market Forecast to 2025 (US$ MN)
4.10.1.1 Interleukins
4.10.1.1.1 Interleukins Market Forecast to 2025 (US$ MN)
4.10.1.2 Enzyme Replacement
4.10.1.2.1 Enzyme Replacement Market Forecast to 2025 (US$ MN)
4.10.1.3 Bone morphogenetic proteins
4.10.1.3.1 Bone morphogenetic proteins Market Forecast to 2025 (US$ MN)
4.10.1.4 Thrombolytic
4.10.1.4.1 Thrombolytic Market Forecast to 2025 (US$ MN)
4.10.1.5 Fc fusion proteins
4.10.1.5.1 Fc fusion proteins Market Forecast to 2025 (US$ MN)
4.10.1.6 Engineered protein scaffolds
4.10.1.6.1 Engineered protein scaffolds Market Forecast to 2025 (US$ MN)
4.10.1.7 Cytokines
4.10.1.7.1 Cytokines Market Forecast to 2025 (US$ MN)
5 Protein Therapeutics Market, By Application
5.1 Autoimmune diseases
5.1.1 Autoimmune diseases Market Forecast to 2025 (US$ MN)
5.2 Infectious diseases
5.2.1 Infectious diseases Market Forecast to 2025 (US$ MN)
5.3 Protein vaccine
5.3.1 Protein vaccine Market Forecast to 2025 (US$ MN)
5.4 Cancer
5.4.1 Cancer Market Forecast to 2025 (US$ MN)
5.5 Fertility
5.5.1 Fertility Market Forecast to 2025 (US$ MN)
5.6 Hematopoiesis
5.6.1 Hematopoiesis Market Forecast to 2025 (US$ MN)
5.7 Metabolic and endocrine disorders
5.7.1 Metabolic and endocrine disorders Market Forecast to 2025 (US$ MN)
6 Protein Therapeutics Market, By End User
6.1 Pharmaceutical companies
6.1.1 Pharmaceutical companies Market Forecast to 2025 (US$ MN)
6.2 Healthcare service providers
6.2.1 Healthcare service providers Market Forecast to 2025 (US$ MN)
6.3 Research Organizations
6.3.1 Research Organizations Market Forecast to 2025 (US$ MN)
6.4 Academic Research Institutes
6.4.1 Academic Research Institutes Market Forecast to 2025 (US$ MN)
7 Protein Therapeutics Market, By Function
7.1 Protein diagnostics
7.1.1 Protein diagnostics Market Forecast to 2025 (US$ MN)
7.2 Special targeting activity
7.2.1 Special targeting activity Market Forecast to 2025 (US$ MN)
7.3 Enzymatic and regulatory activity
7.3.1 Enzymatic and regulatory activity Market Forecast to 2025 (US$ MN)
7.4 Vaccines
7.4.1 Vaccines Market Forecast to 2025 (US$ MN)
8 Protein Therapeutics Market, By Geography
8.1 North America
8.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
8.1.1.1 US
8.1.1.2 Canada
8.1.1.3 Mexico
8.2 Europe
8.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
8.2.1.1 France
8.2.1.2 Germany
8.2.1.3 Italy
8.2.1.4 Spain
8.2.1.5 UK
8.2.1.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
8.3.1.1 China
8.3.1.2 Japan
8.3.1.3 India
8.3.1.4 Australia
8.3.1.5 New Zealand
8.3.1.6 Rest of Asia
8.4 Middle East
8.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
8.4.1.1 Saudi Arabia
8.4.1.2 UAE
8.4.1.3 Rest of Middle East
8.5 Latin America
8.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
8.5.1.1 Argentina
8.5.1.2 Brazil
8.5.1.3 Rest of Latin America
8.6 Rest of the World (RoW)
8.6.1RoW Market Forecast by Countries to 2025 (US$ MN)
8.6.1.1Africa
8.6.1.2Caribbean
9 Key Player Activities
9.1 Acquisitions & Mergers
9.2 Agreements, Partnerships, Collaborations and Joint Ventures
9.3 Product Launch & Expansions
9.4 Other Activities
10 Leading Companies
10.1 Novo Nordisk
10.2 Johnson & Johnson
10.3 Eli Lilly & Company
10.4 Group Biogen Idec Inc
10.5 Merck Serono S.A
10.6 Amgen Inc
10.7 Abbott Laboratories
10.8 Genetech
10.9 F. Hoffmann-La Roche
10.10 Amgen Inc.
10.11 AstraZeneca
10.12 Baxter International
10.13 Boehringer Ingelheim
10.14 Chugai Pharmaceutical
10.15 Diasome Pharmaceuticals
10.16 Generex Biotechnology
10.17 GeneScience Pharmaceuticals,
10.18 Kyowa Hakko Kirin
10.19 Oramed Pharmaceuticals
10.20 Sandoz International
10.21 Teva Pharmaceutical Industries
10.22 Hualan Biological Engineering
List of Tables
Table 1 Global Protein Therapeutics Market By Region, Market Forecast (2013-2025) (US $MN)
Table 2 Global Protein Therapeutics Market By Therapeutic Proteins, Market Forecast (2013-2025) (US $MN)
Table 3 Global Protein Therapeutics Market By Monoclonal Antibodies(mAbs), Market Forecast (2013-2025) (US $MN)
Table 4 Global Protein Therapeutics Market By Erythropoietin (EPO), Market Forecast (2013-2025) (US $MN)
Table 5 Global Protein Therapeutics Market By Insulin, Market Forecast (2013-2025) (US $MN)
Table 6 Global Protein Therapeutics Market By Interferon (IFN), Market Forecast (2013-2025) (US $MN)
Table 7 Global Protein Therapeutics Market By Human Growth Hormone (HGH), Market Forecast (2013-2025) (US $MN)
Table 8 Global Protein Therapeutics Market By Follicle Stimulating Hormone (FSH), Market Forecast (2013-2025) (US $MN)
Table 9 Global Protein Therapeutics Market By Blood Clotting Factors, Market Forecast (2013-2025) (US $MN)
Table 10 Global Protein Therapeutics Market By Granulocyte-colony stimulating factor (G-CSF), Market Forecast (2013-2025) (US $MN)
Table 11 Global Protein Therapeutics Market By Colony Stimulating factor, Market Forecast (2013-2025) (US $MN)
Table 12 Global Protein Therapeutics Market By Other Proteins, Market Forecast (2013-2025) (US $MN)
Table 13 Global Protein Therapeutics Market By Interleukins, Market Forecast (2013-2025) (US $MN)
Table 14 Global Protein Therapeutics Market By Enzyme Replacement, Market Forecast (2013-2025) (US $MN)
Table 15 Global Protein Therapeutics Market By Bone morphogenetic proteins, Market Forecast (2013-2025) (US $MN)
Table 16 Global Protein Therapeutics Market By Thrombolytic, Market Forecast (2013-2025) (US $MN)
Table 17 Global Protein Therapeutics Market By Fc fusion proteins, Market Forecast (2013-2025) (US $MN)
Table 18 Global Protein Therapeutics Market By Engineered protein scaffolds, Market Forecast (2013-2025) (US $MN)
Table 19 Global Protein Therapeutics Market By Cytokines, Market Forecast (2013-2025) (US $MN)
Table 20 Global Protein Therapeutics Market By Application, Market Forecast (2013-2025) (US $MN)
Table 21 Global Protein Therapeutics Market By Autoimmune diseases, Market Forecast (2013-2025) (US $MN)
Table 22 Global Protein Therapeutics Market By Infectious diseases, Market Forecast (2013-2025) (US $MN)
Table 23 Global Protein Therapeutics Market By Protein vaccine, Market Forecast (2013-2025) (US $MN)
Table 24 Global Protein Therapeutics Market By Cancer, Market Forecast (2013-2025) (US $MN)
Table 25 Global Protein Therapeutics Market By Fertility, Market Forecast (2013-2025) (US $MN)
Table 26 Global Protein Therapeutics Market By Hematopoiesis, Market Forecast (2013-2025) (US $MN)
Table 27 Global Protein Therapeutics Market By Metabolic and endocrine disorders, Market Forecast (2013-2025) (US $MN)
Table 28 Global Protein Therapeutics Market By End User, Market Forecast (2013-2025) (US $MN)
Table 29 Global Protein Therapeutics Market By Pharmaceutical companies, Market Forecast (2013-2025) (US $MN)
Table 30 Global Protein Therapeutics Market By Healthcare service providers, Market Forecast (2013-2025) (US $MN)
Table 31 Global Protein Therapeutics Market By Research Organizations, Market Forecast (2013-2025) (US $MN)
Table 32 Global Protein Therapeutics Market By Academic Research Institutes, Market Forecast (2013-2025) (US $MN)
Table 33 Global Protein Therapeutics Market By Function, Market Forecast (2013-2025) (US $MN)
Table 34 Global Protein Therapeutics Market By Protein diagnostics, Market Forecast (2013-2025) (US $MN)
Table 35 Global Protein Therapeutics Market By Special targeting activity, Market Forecast (2013-2025) (US $MN)
Table 36 Global Protein Therapeutics Market By Enzymatic and regulatory activity, Market Forecast (2013-2025) (US $MN)
Table 37 Global Protein Therapeutics Market By Vaccines, Market Forecast (2013-2025) (US $MN)
Table 38 North America Protein Therapeutics Market By Country, Market Forecast (2013-2025) (US $MN)
Table 39 North America Protein Therapeutics Market By Therapeutic Proteins, Market Forecast (2013-2025) (US $MN)
Table 40 North America Protein Therapeutics Market By Monoclonal Antibodies(mAbs), Market Forecast (2013-2025) (US $MN)
Table 41 North America Protein Therapeutics Market By Erythropoietin (EPO), Market Forecast (2013-2025) (US $MN)
Table 42 North America Protein Therapeutics Market By Insulin, Market Forecast (2013-2025) (US $MN)
Table 43 North America Protein Therapeutics Market By Interferon (IFN), Market Forecast (2013-2025) (US $MN)
Table 44 North America Protein Therapeutics Market By Human Growth Hormone (HGH), Market Forecast (2013-2025) (US $MN)
Table 45 North America Protein Therapeutics Market By Follicle Stimulating Hormone (FSH), Market Forecast (2013-2025) (US $MN)
Table 46 North America Protein Therapeutics Market By Blood Clotting Factors, Market Forecast (2013-2025) (US $MN)
Table 47 North America Protein Therapeutics Market By Granulocyte-colony stimulating factor (G-CSF), Market Forecast (2013-2025) (US $MN)
Table 48 North America Protein Therapeutics Market By Colony Stimulating factor, Market Forecast (2013-2025) (US $MN)
Table 49 North America Protein Therapeutics Market By Other Proteins, Market Forecast (2013-2025) (US $MN)
Table 50 North America Protein Therapeutics Market By Interleukins, Market Forecast (2013-2025) (US $MN)
Table 51 North America Protein Therapeutics Market By Enzyme Replacement, Market Forecast (2013-2025) (US $MN)
Table 52 North America Protein Therapeutics Market By Bone morphogenetic proteins, Market Forecast (2013-2025) (US $MN)
Table 53 North America Protein Therapeutics Market By Thrombolytic, Market Forecast (2013-2025) (US $MN)
Table 54 North America Protein Therapeutics Market By Fc fusion proteins, Market Forecast (2013-2025) (US $MN)
Table 55 North America Protein Therapeutics Market By Engineered protein scaffolds, Market Forecast (2013-2025) (US $MN)
Table 56 North America Protein Therapeutics Market By Cytokines, Market Forecast (2013-2025) (US $MN)
Table 57 North America Protein Therapeutics Market By Application, Market Forecast (2013-2025) (US $MN)
Table 58 North America Protein Therapeutics Market By Autoimmune diseases, Market Forecast (2013-2025) (US $MN)
Table 59 North America Protein Therapeutics Market By Infectious diseases, Market Forecast (2013-2025) (US $MN)
Table 60 North America Protein Therapeutics Market By Protein vaccine, Market Forecast (2013-2025) (US $MN)
Table 61 North America Protein Therapeutics Market By Cancer, Market Forecast (2013-2025) (US $MN)
Table 62 North America Protein Therapeutics Market By Fertility, Market Forecast (2013-2025) (US $MN)
Table 63 North America Protein Therapeutics Market By Hematopoiesis, Market Forecast (2013-2025) (US $MN)
Table 64 North America Protein Therapeutics Market By Metabolic and endocrine disorders, Market Forecast (2013-2025) (US $MN)
Table 65 North America Protein Therapeutics Market By End User, Market Forecast (2013-2025) (US $MN)
Table 66 North America Protein Therapeutics Market By Pharmaceutical companies, Market Forecast (2013-2025) (US $MN)
Table 67 North America Protein Therapeutics Market By Healthcare service providers, Market Forecast (2013-2025) (US $MN)
Table 68 North America Protein Therapeutics Market By Research Organizations, Market Forecast (2013-2025) (US $MN)
Table 69 North America Protein Therapeutics Market By Academic Research Institutes, Market Forecast (2013-2025) (US $MN)
Table 70 North America Protein Therapeutics Market By Function, Market Forecast (2013-2025) (US $MN)
Table 71 North America Protein Therapeutics Market By Protein diagnostics, Market Forecast (2013-2025) (US $MN)
Table 72 North America Protein Therapeutics Market By Special targeting activity, Market Forecast (2013-2025) (US $MN)
Table 73 North America Protein Therapeutics Market By Enzymatic and regulatory activity, Market Forecast (2013-2025) (US $MN)
Table 74 North America Protein Therapeutics Market By Vaccines, Market Forecast (2013-2025) (US $MN)
Table 75 Europe Protein Therapeutics Market By Country, Market Forecast (2013-2025) (US $MN)
Table 76 Europe Protein Therapeutics Market By Therapeutic Proteins, Market Forecast (2013-2025) (US $MN)
Table 77 Europe Protein Therapeutics Market By Monoclonal Antibodies(mAbs), Market Forecast (2013-2025) (US $MN)
Table 78 Europe Protein Therapeutics Market By Erythropoietin (EPO), Market Forecast (2013-2025) (US $MN)
Table 79 Europe Protein Therapeutics Market By Insulin, Market Forecast (2013-2025) (US $MN)
Table 80 Europe Protein Therapeutics Market By Interferon (IFN), Market Forecast (2013-2025) (US $MN)
Table 81 Europe Protein Therapeutics Market By Human Growth Hormone (HGH), Market Forecast (2013-2025) (US $MN)
Table 82 Europe Protein Therapeutics Market By Follicle Stimulating Hormone (FSH), Market Forecast (2013-2025) (US $MN)
Table 83 Europe Protein Therapeutics Market By Blood Clotting Factors, Market Forecast (2013-2025) (US $MN)
Table 84 Europe Protein Therapeutics Market By Granulocyte-colony stimulating factor (G-CSF), Market Forecast (2013-2025) (US $MN)
Table 85 Europe Protein Therapeutics Market By Colony Stimulating factor, Market Forecast (2013-2025) (US $MN)
Table 86 Europe Protein Therapeutics Market By Other Proteins, Market Forecast (2013-2025) (US $MN)
Table 87 Europe Protein Therapeutics Market By Interleukins, Market Forecast (2013-2025) (US $MN)
Table 88 Europe Protein Therapeutics Market By Enzyme Replacement, Market Forecast (2013-2025) (US $MN)
Table 89 Europe Protein Therapeutics Market By Bone morphogenetic proteins, Market Forecast (2013-2025) (US $MN)
Table 90 Europe Protein Therapeutics Market By Thrombolytic, Market Forecast (2013-2025) (US $MN)
Table 91 Europe Protein Therapeutics Market By Fc fusion proteins, Market Forecast (2013-2025) (US $MN)
Table 92 Europe Protein Therapeutics Market By Engineered protein scaffolds, Market Forecast (2013-2025) (US $MN)
Table 93 Europe Protein Therapeutics Market By Cytokines, Market Forecast (2013-2025) (US $MN)
Table 94 Europe Protein Therapeutics Market By Application, Market Forecast (2013-2025) (US $MN)
Table 95 Europe Protein Therapeutics Market By Autoimmune diseases, Market Forecast (2013-2025) (US $MN)
Table 96 Europe Protein Therapeutics Market By Infectious diseases, Market Forecast (2013-2025) (US $MN)
Table 97 Europe Protein Therapeutics Market By Protein vaccine, Market Forecast (2013-2025) (US $MN)
Table 98 Europe Protein Therapeutics Market By Cancer, Market Forecast (2013-2025) (US $MN)
Table 99 Europe Protein Therapeutics Market By Fertility, Market Forecast (2013-2025) (US $MN)
Table 100 Europe Protein Therapeutics Market By Hematopoiesis, Market Forecast (2013-2025) (US $MN)
Table 101 Europe Protein Therapeutics Market By Metabolic and endocrine disorders, Market Forecast (2013-2025) (US $MN)
Table 102 Europe Protein Therapeutics Market By End User, Market Forecast (2013-2025) (US $MN)
Table 103 Europe Protein Therapeutics Market By Pharmaceutical companies, Market Forecast (2013-2025) (US $MN)
Table 104 Europe Protein Therapeutics Market By Healthcare service providers, Market Forecast (2013-2025) (US $MN)
Table 105 Europe Protein Therapeutics Market By Research Organizations, Market Forecast (2013-2025) (US $MN)
Table 106 Europe Protein Therapeutics Market By Academic Research Institutes, Market Forecast (2013-2025) (US $MN)
Table 107 Europe Protein Therapeutics Market By Function, Market Forecast (2013-2025) (US $MN)
Table 108 Europe Protein Therapeutics Market By Protein diagnostics, Market Forecast (2013-2025) (US $MN)
Table 109 Europe Protein Therapeutics Market By Special targeting activity, Market Forecast (2013-2025) (US $MN)
Table 110 Europe Protein Therapeutics Market By Enzymatic and regulatory activity, Market Forecast (2013-2025) (US $MN)
Table 111 Europe Protein Therapeutics Market By Vaccines, Market Forecast (2013-2025) (US $MN)
Note: Asia Pacific, Middle East, Latin America and RoW are represented in above similar manner.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report